Plasma-derived cfDNA to reveal potential biomarkers of response prediction and monitoring in non-small cell lung cancer (NSCLC) patients on immunotherapy.

Francesco Vallania,Karen Assayag,Peter Ulz,Adam Drake,Hayley Warsinske,John St. John,Girish Putcha,Luc Cabel,Sophie Beaucaire-Danel,Nicolas Girard,François-Clément Bidard

Plasma-derived cfDNA to reveal potential biomarkers of response prediction and monitoring in non-small cell lung cancer (NSCLC) patients on immunotherapy.

2020

Francesco Vallania
Karen Assayag
Peter Ulz
Adam Drake
Hayley Warsinske
John St. John
Girish Putcha
Luc Cabel
Sophie Beaucaire-Danel
Nicolas Girard
François-Clément Bidard

9588Background: Immune checkpoint inhibitors have shown promising results in many advanced cancers, but the response rate remains low. Various molecular and cellular biomarkers, such as elevated tu...

Keywords:

Oncology
plasma derived
Internal medicine
Pathology
potential biomarkers
Immunotherapy
Medicine
non-small cell lung cancer (NSCLC)

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations